84 microarray experimental samples list

Array ID Sample Name Before and after pair (yes or no), and other comments
svcc98.2 NORWAY 7-BE yes
svcc63.2 NORWAY 7-AF yes
svcc78.2 NORWAY 10-BE yes
svcc77.2 NORWAY 10-AF yes
svcc122.2 NORWAY 11 no, no after
svcc68.2 NORWAY 19 no, no after
svcc53.2 NORWAY 12-BE yes
svcc97.2 NORWAY 12-AF yes
svcc81.2 NORWAY 14-BE yes
svcc52.2 NORWAY 14-AF yes
svcc106.2 NORWAY 15-BE yes
svcc64.2 NORWAY 15-AF yes
svcc108.2 NORWAY 16 no, no after
svcc88.2 NORWAY 17 no, no after
svcc134.2 NORWAY 18-BE yes
svcc112.2 NORWAY 18-AF yes
svcc89.2 NORWAY 26-BE yes
svcc91.2 NORWAY 26-AF yes
svcc111.2 NORWAY 27-BE yes
svcc109.2 NORWAY 27-AF yes
svcc1077.2 NEW YORK 1 no
svcc132.2 NEW YORK 2 no
svcc61.2 STANFORD 14 no
svcc137.2 STANFORD 16 no
svcc119.2 STANFORD 17 no
svcc96.2 STANFORD 2-P primary tumor, paired with a metastasis
svcc113.2 STANFORD 2-LN lymph node metastasis from tumor Stanford 2
svcc93.2 NORWAY 39-BE yes
svcc135.2 NORWAY 39-AF yes
svcc107.2 NORWAY 41-BE yes
svcc125.2 NORWAY 41-AF yes
svcc76.2 NORWAY 47-BE yes
svcc79.2 NORWAY 47-AF yes
svcc92.2 NORWAY 48-BE yes
svcc103.2 NORWAY 48-AF yes
svcc99.2 STANFORD 23 no
svcc100.2 STANFORD 24 no
svcc131.2 NORWAY 53-BE yes
svcc58.2 NORWAY 53-AF yes
svcc87.2 NORWAY 56 no, no after
svcc51.2 NORWAY 57 no, no after
svcc118.2 STANFORD 35 no
svcc117.2 STANFORD 37-FA no
svcc115.2 STANFORD 38-P primary tumor, paired with a metastasis
svcc116.2 STANFORD 38-LN lymph node metastasis from tumor Stanford 38
svcc83.2 NORWAY 61-BE yes
svcc66.2 NORWAY 61-AF yes
svcc123.2 NORWAY 65 no, no after
svcc104.2 NORWAY 100-BE yes
svcc86.2 NORWAY 100-AF yes
svcc84.2 NORWAY 101-BE yes
svcc85.2 NORWAY 101-AF yes
svcc101.2 NORWAY 102-BE yes
svcc82.2 NORWAY 102-AF yes
svcc120.2 NORWAY 104-BE yes
svcc65.2 NORWAY 104-AF yes
svcc130.2 NEW YORK 3 no
svcc105.2 NORWAY 109-BE yes
svcc121.2 NORWAY 109-AF yes
svcc55.2 NORWAY 111 no, no after
svcc124.2 NORWAY 112-BE yes
svcc126.2 NORWAY 112-AF yes
svcc70.2 NORMAL 1 Normal Breast 1 (6 pooled whole nomal breasts specimens)
svcc127.2 NORMAL 2 Normal Breast 2 (2 pooled whole nomral breast specimens)
svcc18.2 NORMAL 3 Norway Normal Breast 1 (a sample from a single individual)
svcc128.2 BT-474 cell line; luminal epithelial, ERBB2 positive
svcc69.2 BT-549 cell line; breast derived
svcc500.2 HMEC+IFNa cell line; HMEC-C isolate, basal epithelial cell line plus IFNa
svcc94.2 HMEC-C cell line; HMEC-C isolate, basal epithelial cell line untreated
svcc47.2 HMEC-C CON cell line; HMEC-C isolate, basal epithelial cell line after 2 days at 100% confluence
svcc41.2 HMVEC cell line; human dermal microvacsular endothelial cells
svcc110.2 Hs578T cell line; breast carcinosarcoma derived
svcc42.2 HUVEC cell line; human umbilical vein derived endothelial cell line
svcc1299.2 MCF7 cell line; luminal epithelial, estrogen receptor positive
svcc73.2 MDA-MB-231 cell line; breast tissue derived cell line
svcc72.2 MOLT4 cell line; t-cell leukemia derived
svcc67.2 NB4+ATRA cell line; neutrophil-like after Retinoic Acid induced differentiation (72 hours)
svcc54.2 RPMI-8226 cell line; b-cell like (derived from a multiple myeloma)
svcc15.2 SK-BR-3 cell line; luminal epithelial, ERBB2 positive
svcc74.2 SW872 cell line; liposacroma derived cell line
svcc71.2 T47D cell line; luminal epithelial, estrogen receptor positive
svcc38.2 184A1 cell line; basal epithelial, immortal derivative of 184Aa
svcc17.2 184Aa cell line; basal epithelial, a second HMEC isolate unrelated to HMEC-C
svcc40.2 184B5 cell line; basal epithelial, immortal derivative of 184Aa

Last Updated on 05/04/2000
By Charles M. Perou
Email: perou@genome.stanford.edu